Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
JD.com
JD
$39.4B
| $9.56M | 0.02% |
+375,705
| New | +$9.79M |
|
952
Humana
HUM
$46.4B
| $9.54M | 0.02% |
46,760
+27,144
| +138% | +$5.18M |
|
|
ETP
953
DELISTED
Energy Transfer Partners, L.P.
ETP
| $9.5M | 0.02% |
395,587
-272,661
| -41% | -$6.89M |
|
954
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
| $9.5M | 0.02% |
79,745
+43,890
| +122% | +$5.5M |
|
955
Silicon Laboratories
SLAB
$7.28B
| $9.48M | 0.02% |
145,796
+48,590
| +50% | +$3.06M |
|
|
TGP
956
DELISTED
Teekay LNG Partners L.P.
TGP
| $9.45M | 0.02% |
653,719
-206,270
| -24% | -$3.07M |
|
|
APOL
957
DELISTED
Apollo Education Group Inc Class A
APOL
| $9.42M | 0.02% |
951,334
+938,529
| +7,329% | +$8.56M |
|
958
Gray Television
GTN
$507M
| $9.41M | 0.02% |
866,941
+677,219
| +357% | +$6.65M |
|
959
BCE
BCE
$22.2B
| $9.4M | 0.02% |
217,313
+182,746
| +529% | +$8.07M |
|
960
CALL
Edwards Lifesciences
EW
$52.2B
| $9.37M | 0.02% |
300,000
+90,000
| +43% | +$2.92M |
|
961
Sarepta Therapeutics
SRPT
$1.92B
| $9.37M | 0.02% |
341,497
-1,614,407
| -83% | -$64.8M |
|
|
AMRN
962
Amarin Corp
AMRN
$292M
| $9.36M | 0.02% |
151,877
+79,522
| +110% | +$5.05M |
|
|
DYN
963
DELISTED
Dynegy, Inc.
DYN
| $9.34M | 0.02% |
1,103,655
-936,550
| -46% | -$9.23M |
|
|
NDRM
964
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $9.33M | 0.02% |
+420,299
| New | +$7.86M |
|
965
Xylem
XYL
$26.7B
| $9.33M | 0.02% |
+188,321
| New | +$9.55M |
|
966
Energy Recovery
ERII
$398M
| $9.32M | 0.02% |
900,918
+477,119
| +113% | +$5.73M |
|
|
KYNB
967
Kyntra Bio
KYNB
$32.3M
| $9.3M | 0.02% |
17,380
+3,212
| +23% | +$1.6M |
|
968
PUT
Caterpillar
CAT
$373B
| $9.27M | 0.02% |
100,000
+70,000
| +233% | +$6.34M |
|
969
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.54B
| $9.26M | 0.02% |
301,251
-261,929
| -47% | -$8.02M |
|
970
COPT Defense Properties
CDP
$4.25B
| $9.25M | 0.02% |
296,408
-89,164
| -23% | -$2.53M |
|
|
ACOR
971
DELISTED
Acorda Therapeutics
ACOR
| $9.24M | 0.02% |
4,096
+2,030
| +98% | +$4.83M |
|
972
MPLX
MPLX
$59.3B
| $9.23M | 0.02% |
+266,621
| New | +$8.66M |
|
|
HT
973
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $9.18M | 0.02% |
426,789
+282,236
| +195% | +$5.51M |
|
974
Apollo Global Management
APO
$78.4B
| $9.15M | 0.02% |
+472,793
| New | +$8.93M |
|
975
Rogers Communications
RCI
$19.7B
| $9.15M | 0.02% |
237,202
+222,418
| +1,504% | +$8.78M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.